Jared Putnam
Psychiatry · Chevy Chase, MDNPI 1992775993
Payments from drug & device makers
Across 222 payments — averaging $19.80 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Sunovion Pharmaceuticals Inc.$1K
- Lundbeck LLC$788
- AbbVie$486
- Otsuka America Pharmaceutical, Inc.$310
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$235
- AstraZeneca$226
- plus $1K from 13 others
What the payments were for
- Speaking & faculty fees$3458%
- Food & beverage$3,90389%
- Education$1473%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Sunovion Pharmaceuticals Inc. | 41 | $1,269 |
| Lundbeck LLC | 40 | $788 |
| AbbVie(2 entities) | 33 | $486 |
| Otsuka America Pharmaceutical, Inc. | 32 | $310 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 8 | $235 |
| AstraZeneca | 2 | $226 |
| Vanda Pharmaceuticals Inc. | 16 | $206 |
| Takeda Pharmaceuticals U.S.A., Inc. | 14 | $176 |
| Tris Pharma Inc | 8 | $156 |
| Aerin Medical Inc. | 1 | $144 |
| Bausch Health US, LLC | 7 | $107 |
| Neos Therapeutics, LP | 6 | $87 |
| Johnson & Johnson | 4 | $54 |
| Arbor Pharmaceuticals, Inc. | 3 | $44 |
| Avanir Pharmaceuticals, Inc. | 2 | $29 |
| Ironshore Pharmaceuticals Inc. | 2 | $28 |
| Alkermes, Inc. | 1 | $22 |
| Jazz Pharmaceuticals Inc. | 1 | $15 |
| Neurocrine Biosciences, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- LATUDA$345
- FASENRA$226
- VIVAER STYLUS$144
- RHINAER STYLUS$144
How this compares
$4,395 in reported general payments places this provider in the 85th percentile of 851 psychiatry providers in Maryland.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| VraylarCariprazine Hcl | 19 | $31,354 |
| TrintellixVortioxetine Hydrobromide | 25 | $20,293 |
| VyvanseLisdexamfetamine Dimesylate | 27 | $10,509 |
| Bupropion XlBupropion Hcl | 155 | $4,942 |
| Gabapentin | 185 | $3,509 |
| Vilazodone Hcl | 29 | $3,494 |
| Lurasidone Hcl | 19 | $3,135 |
| Aripiprazole | 44 | $2,844 |
| Desvenlafaxine Succinate ErDesvenlafaxine Succinate | 55 | $2,738 |
| Clozapine | 42 | $2,706 |
| Escitalopram Oxalate | 106 | $2,400 |
| Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine | 69 | $2,115 |
| Pramipexole DihydrochloridePramipexole Di-Hcl | 39 | $2,076 |
| Dextroamphetamine-Amphet ErDextroamphetamine/Amphetamine | 14 | $2,063 |
| Clonazepam | 156 | $1,965 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieVraylar | $486 | $31,35419 claims |
| Takeda Pharmaceuticals U.S.A., Inc.Trintellix, Vyvanse | $176 | $30,80252 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 851 psychiatry providers in Maryland.
Other psychiatry in Chevy Chase
- Robert PostChevy Chase$66K
- Gonzalo LajeChevy Chase$29K
- Elia Acevedo DiazGaithersburg$15.8M
- Akira SawaBaltimore$5.1M
- John VaethBaltimore$2.1M
- Paul RosenbergBaltimore$1.9M
- Scott AaronsonBaltimore$1.3M
- Karen AndersonBaltimore$1.1M
- Constantine LyketsosBaltimore$1.1M
- Alan JonasBaltimore$1.1M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.